デフォルト表紙
市場調査レポート
商品コード
1660902

DNAおよびRNAサンプル調製の世界市場:業界分析、規模、シェア、成長、動向、予測(2025年~2032年)

DNA and RNA Sample Preparation Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032


出版日
ページ情報
英文 186 Pages
納期
2~5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
DNAおよびRNAサンプル調製の世界市場:業界分析、規模、シェア、成長、動向、予測(2025年~2032年)
出版日: 2025年02月18日
発行: Persistence Market Research
ページ情報: 英文 186 Pages
納期: 2~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のDNAおよびRNAサンプル調製の市場規模は、2025年に21億2,000万米ドルになるとみられ、2025年~2032年の予測期間に5.7%のCAGRで拡大し、2032年には31億1,000万米ドルに達すると予測されています。

DNAおよびRNAサンプル調製市場には、DNAおよびRNAサンプルを効率的に抽出、精製、処理するために設計された様々な試薬、キット、自動化機器が含まれます。これらの製品は、ゲノミクス、分子診断、創薬、法医学分析を含む様々な用途に不可欠です。同市場は、学術研究機関、バイオテクノロジー・製薬企業、病院、診断研究所など、多様なセグメントにサービスを提供しています。ハイスループットシーケンシングの需要の増加、分子生物学技術の進歩、遺伝性疾患や感染症の有病率の上昇などが成長の原動力となっています。

世界のDNAおよびRNAサンプル調製市場を牽引している主な要因はいくつかあります。次世代シーケンシング(NGS)やポリメラーゼ連鎖反応(PCR)技術の採用拡大が、効率的なサンプル調製ソリューションの需要を押し上げています。自動サンプル調製ワークフローにおける技術の進歩は、効率性と再現性を高め、汚染や人為的ミスのリスクを低減します。さらに、遺伝子研究や個別化医療への投資の増加が市場成長を後押ししています。迅速で高品質な核酸抽出法の需要は、感染症発生やがん研究の増加によってさらに促進されています。抽出キットや試薬の技術革新とともに研究開発活動が強化され、さまざまな用途により堅牢なソリューションを提供することで市場の成長に寄与しています。

この市場は、サンプル調製ワークフローにおける自動化と小型化の採用の増加により、大きな機会をもたらしています。リキッドバイオプシーや非侵襲的診断技術への注目の高まりは、新規DNAおよびRNA抽出キットの開発に新たな道を開く。シングルセルシーケンシングとメタゲノミクスの進歩は、より深い生物学的洞察を可能にすることで、市場の可能性をさらに拡大します。バイオ医薬品研究の拡大と核酸ベースの治療薬に対する需要の高まりは、有利な成長見通しを示しています。戦略的パートナーシップ、持続可能で環境に優しい試薬への投資、高収率でコンタミネーションのないサンプル調製製品のイントロダクションは、新たな機会を活用し、市場のリーダーシップを維持するために不可欠です。

当レポートでは、世界のDNAおよびRNAサンプル調製市場について調査し、製品別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の範囲と定義
  • 市場力学
  • マクロ経済要因
  • COVID-19の影響分析
  • 予測要因- 関連性と影響

第3章 付加価値の洞察

第4章 世界のDNAおよびRNAサンプル調製市場の見通し

  • 主なハイライト
  • 市場規模(10億米ドル)分析と予測
  • 世界のDNAおよびRNAサンプル調製市場の見通し:製品別
  • 世界のDNAおよびRNAサンプル調製市場の見通し:用途別
  • 世界のDNAおよびRNAサンプル調製市場の見通し:エンドユーザー別

第5章 世界のDNAおよびRNAサンプル調製市場の見通し:地域別

  • 主なハイライト
  • 過去の市場規模(10億米ドル)分析、地域別、2019年~2024年
  • 現在の市場規模(10億米ドル)分析と予測、地域別、2025年~2032年
  • 市場の魅力分析:地域別

第6章 北米のDNAおよびRNAサンプル調製市場の見通し

第7章 欧州のDNAおよびRNAサンプル調製市場の見通し

第8章 東アジアのDNAおよびRNAサンプル調製市場の見通し

第9章 南アジアおよびオセアニアのDNAおよびRNAサンプル調製市場の見通し

第10章 ラテンアメリカのDNAおよびRNAサンプル調製市場の見通し

第11章 中東・アフリカのDNAおよびRNAサンプル調製市場の見通し

第12章 競合情勢

  • 市場シェア分析、2025年
  • 市場構造
  • 企業プロファイル(詳細- 概要、財務、戦略、最近の動向)
    • Thermo Fisher Scientific Inc.
    • Isogen Lifescience B.V.
    • MP Biomedicals
    • Minerva Biolabs GmbH
    • QIAGEN
    • Bio-Rad Laboratories, Inc
    • Merck KGaA
    • Agilent Technologies, Inc.
    • c-LEcta GmbH
    • Beckman Coulter, Inc.
    • Bioresearch Technologies
    • Promega Corporation
    • Illumina, Inc.
    • Aurora Biomed Inc.
    • Hygiena LLC
    • Tecan Trading AG
    • MACHEREY-NAGEL GmbH & Co. KG
    • Ahlstrom
    • Nanodigmbio (Nanjing) Biotechnology Co., Ltd.
    • Bionano Genomics, Inc.
    • Revvity
    • F. Hoffmann-La Roche Ltd
    • New England Biolabs

第13章 付録

目次
Product Code: PMRREP3211

Persistence Market Research has recently published an extensive report on the global DNA and RNA Sample Preparation Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

  • DNA and RNA Sample Preparation Market Size (2025E): USD 2.12 Bn
  • Projected Market Value (2032F): USD 3.11 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 5.7%

DNA and RNA Sample Preparation Market - Report Scope:

The DNA and RNA Sample Preparation Market encompasses a variety of reagents, kits, and automated instruments designed to extract, purify, and process DNA and RNA samples efficiently. These products are crucial for various applications, including genomics, molecular diagnostics, drug discovery, and forensic analysis. The market serves diverse segments such as academic research institutes, biotechnology and pharmaceutical companies, hospitals, and diagnostic laboratories. Growth is driven by increasing demand for high-throughput sequencing, advancements in molecular biology techniques, and the rising prevalence of genetic disorders and infectious diseases.

Market Growth Drivers:

Several key factors are driving the global DNA and RNA Sample Preparation Market. The growing adoption of next-generation sequencing (NGS) and polymerase chain reaction (PCR) technologies is boosting demand for efficient sample preparation solutions. Technological advancements in automated sample preparation workflows enhance efficiency and reproducibility, reducing the risk of contamination and human error. Additionally, increasing investments in genetic research and personalized medicine are fueling market growth. The demand for rapid and high-quality nucleic acid extraction methods is further propelled by the rise in infectious disease outbreaks and cancer research. Enhanced research and development activities, along with innovations in extraction kits and reagents, contribute to market growth by offering more robust solutions for various applications.

Market Restraints:

Despite promising growth prospects, the DNA and RNA Sample Preparation Market faces challenges related to high costs associated with advanced sample preparation kits and automated systems. Market expansion may be hindered by budget constraints in research institutions and small diagnostic laboratories, limiting their ability to invest in premium technologies. Additionally, the complexity of sample preparation protocols and the need for specialized expertise pose challenges for widespread adoption. The presence of alternative techniques, such as direct sample analysis and point-of-care testing, may also impact market growth. Addressing these issues requires continuous innovation in cost-effective and user-friendly sample preparation solutions.

Market Opportunities:

The market presents significant opportunities driven by the increasing adoption of automation and miniaturization in sample preparation workflows. The rising focus on liquid biopsy and non-invasive diagnostic techniques opens new avenues for the development of novel DNA and RNA extraction kits. Advancements in single-cell sequencing and metagenomics further expand the market's potential by enabling deeper biological insights. The expansion of biopharmaceutical research and the growing demand for nucleic acid-based therapeutics present lucrative growth prospects. Strategic partnerships, investments in sustainable and eco-friendly reagents, and the introduction of high-yield and contamination-free sample preparation products are essential for capitalizing on emerging opportunities and maintaining market leadership.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the DNA and RNA Sample Preparation Market globally?
  • Which sample preparation techniques and products are leading the adoption in various applications?
  • How are technological advancements influencing the competitive landscape of the DNA and RNA Sample Preparation Market?
  • Who are the key players in the DNA and RNA Sample Preparation Market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global DNA and RNA Sample Preparation Market?

Competitive Intelligence and Business Strategy:

Leading players in the global DNA and RNA Sample Preparation Market, including Thermo Fisher Scientific, QIAGEN, and Promega Corporation, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced sample preparation solutions and explore new automation technologies. Collaborations with research institutions, diagnostic laboratories, and pharmaceutical companies facilitate market access and promote new product adoption. Emphasis on quality assurance, regulatory compliance, and comprehensive marketing strategies fosters market growth and enhances brand reputation in the evolving DNA and RNA Sample Preparation Market landscape.

Key Companies Profiled:

  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • DiaSorin S.p.A
  • F. Hoffmann-La Roche
  • Illumina, Inc.
  • PerkinElmer, Inc.
  • QIAGEN
  • Merck Millipore
  • Tecan Group AG

DNA and RNA Sample Preparation Market Industry Segmentation

By Product

  • Workstations
  • Kits
  • DNA Sample Preparation
  • RNA Sample Preparation
  • Reagent and Consumables

By Application

  • Clinical Testing
  • Diagnostic Testing
  • Research Application
  • Others

By End User

  • Hospitals
  • Diagnostic Centers
  • Forensic Science Laboratories
  • Academic and Research Institutions
  • Others

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Middle East and Africa
  • Latin America

Table of Contents

1. Executive Summary

  • 1.1. Global DNA and RNA Sample Preparation Market Outlook
  • 1.2. Market DNA and RNA Sample Preparation Market Outlook: Services
  • 1.3. Introduction/Key Findings
  • 1.4. Historical Market Size (US$ Bn) and Analysis, By Services, 2019 - 2024
  • 1.5. Current Market Size (US$ Bn) and Analysis and Forecast, By Services, 2025 - 2032
  • 1.6. Future Market Projections
  • 1.7. Premium Market Insights
  • 1.8. Industry Developments and Key Market Events
  • 1.9. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
  • 3.4. PESTLE Analysis
  • 3.5. Porter's Five Force Analysis

4. Global DNA and RNA Sample Preparation Market Outlook

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019 - 2024
    • 4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025 - 2032
  • 4.3. Global DNA and RNA Sample Preparation Market Outlook: Product
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Product, 2019 - 2024
    • 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025 - 2032
      • 4.3.3.1. Workstations
      • 4.3.3.2. Kits
        • 4.3.3.2.1. DNA Sample Preparation
        • 4.3.3.2.2. RNA Sample Preparation
      • 4.3.3.3. Reagent and Consumables
    • 4.3.4. Market Attractiveness Analysis: Product
  • 4.4. Global DNA and RNA Sample Preparation Market Outlook: Application
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Bn), By Application, 2019 - 2024
    • 4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
      • 4.4.3.1. Clinical Testing
      • 4.4.3.2. Diagnostic Testing
      • 4.4.3.3. Research Application
      • 4.4.3.4. Others
    • 4.4.4. Market Attractiveness Analysis: Application
  • 4.5. Global DNA and RNA Sample Preparation Market Outlook: End User
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019 - 2024
    • 4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 - 2032
      • 4.5.3.1. Hospitals
      • 4.5.3.2. Diagnostic Centers
      • 4.5.3.3. Forensic Science Laboratories
      • 4.5.3.4. Academic & Research Institutions
      • 4.5.3.5. Others
    • 4.5.4. Market Attractiveness Analysis: End User

5. Global DNA and RNA Sample Preparation Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019 - 2024
  • 5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2025 - 2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America DNA and RNA Sample Preparation Market Outlook

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 6.2.1. By Country
    • 6.2.2. By Product
    • 6.2.3. By Application
    • 6.2.4. By End User
  • 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025 - 2032
    • 6.4.1. Workstations
    • 6.4.2. Kits
      • 6.4.2.1. DNA Sample Preparation
      • 6.4.2.2. RNA Sample Preparation
    • 6.4.3. Reagent and Consumables
  • 6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
    • 6.5.1. Clinical Testing
    • 6.5.2. Diagnostic Testing
    • 6.5.3. Research Application
    • 6.5.4. Others
  • 6.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 - 2032
    • 6.6.1. Hospitals
    • 6.6.2. Diagnostic Centers
    • 6.6.3. Forensic Science Laboratories
    • 6.6.4. Academic & Research Institutions
    • 6.6.5. Others
  • 6.7. Market Attractiveness Analysis

7. Europe DNA and RNA Sample Preparation Market Outlook

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Application
    • 7.2.4. By End User
  • 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025 - 2032
    • 7.4.1. Workstations
    • 7.4.2. Kits
      • 7.4.2.1. DNA Sample Preparation
      • 7.4.2.2. RNA Sample Preparation
    • 7.4.3. Reagent and Consumables
  • 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
    • 7.5.1. Clinical Testing
    • 7.5.2. Diagnostic Testing
    • 7.5.3. Research Application
    • 7.5.4. Others
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 - 2032
    • 7.6.1. Hospitals
    • 7.6.2. Diagnostic Centers
    • 7.6.3. Forensic Science Laboratories
    • 7.6.4. Academic & Research Institutions
    • 7.6.5. Others
  • 7.7. Market Attractiveness Analysis

8. East Asia DNA and RNA Sample Preparation Market Outlook

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Application
    • 8.2.4. By End User
  • 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025 - 2032
    • 8.4.1. Workstations
    • 8.4.2. Kits
      • 8.4.2.1. DNA Sample Preparation
      • 8.4.2.2. RNA Sample Preparation
    • 8.4.3. Reagent and Consumables
  • 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
    • 8.5.1. Clinical Testing
    • 8.5.2. Diagnostic Testing
    • 8.5.3. Research Application
    • 8.5.4. Others
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 - 2032
    • 8.6.1. Hospitals
    • 8.6.2. Diagnostic Centers
    • 8.6.3. Forensic Science Laboratories
    • 8.6.4. Academic & Research Institutions
    • 8.6.5. Others
  • 8.7. Market Attractiveness Analysis

9. South Asia & Oceania DNA and RNA Sample Preparation Market Outlook

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Application
    • 9.2.4. By End User
  • 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025 - 2032
    • 9.4.1. Workstations
    • 9.4.2. Kits
      • 9.4.2.1. DNA Sample Preparation
      • 9.4.2.2. RNA Sample Preparation
    • 9.4.3. Reagent and Consumables
  • 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
    • 9.5.1. Clinical Testing
    • 9.5.2. Diagnostic Testing
    • 9.5.3. Research Application
    • 9.5.4. Others
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 - 2032
    • 9.6.1. Hospitals
    • 9.6.2. Diagnostic Centers
    • 9.6.3. Forensic Science Laboratories
    • 9.6.4. Academic & Research Institutions
    • 9.6.5. Others
  • 9.7. Market Attractiveness Analysis

10. Latin America DNA and RNA Sample Preparation Market Outlook

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Application
    • 10.2.4. By End User
  • 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025 - 2032
    • 10.4.1. Workstations
    • 10.4.2. Kits
      • 10.4.2.1. DNA Sample Preparation
      • 10.4.2.2. RNA Sample Preparation
    • 10.4.3. Reagent and Consumables
  • 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
    • 10.5.1. Clinical Testing
    • 10.5.2. Diagnostic Testing
    • 10.5.3. Research Application
    • 10.5.4. Others
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 - 2032
    • 10.6.1. Hospitals
    • 10.6.2. Diagnostic Centers
    • 10.6.3. Forensic Science Laboratories
    • 10.6.4. Academic & Research Institutions
    • 10.6.5. Others
  • 10.7. Market Attractiveness Analysis

11. Middle East & Africa DNA and RNA Sample Preparation Market Outlook

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Application
    • 11.2.4. By End User
  • 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025 - 2032
    • 11.4.1. Workstations
    • 11.4.2. Kits
      • 11.4.2.1. DNA Sample Preparation
      • 11.4.2.2. RNA Sample Preparation
    • 11.4.3. Reagent and Consumables
  • 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
    • 11.5.1. Clinical Testing
    • 11.5.2. Diagnostic Testing
    • 11.5.3. Research Application
    • 11.5.4. Others
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 - 2032
    • 11.6.1. Hospitals
    • 11.6.2. Diagnostic Centers
    • 11.6.3. Forensic Science Laboratories
    • 11.6.4. Academic & Research Institutions
    • 11.6.5. Others
  • 11.7. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2025
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Thermo Fisher Scientific Inc.
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Isogen Lifescience B.V.
    • 12.3.3. MP Biomedicals
    • 12.3.4. Minerva Biolabs GmbH
    • 12.3.5. QIAGEN
    • 12.3.6. Bio-Rad Laboratories, Inc
    • 12.3.7. Merck KGaA
    • 12.3.8. Agilent Technologies, Inc.
    • 12.3.9. c-LEcta GmbH
    • 12.3.10. Beckman Coulter, Inc.
    • 12.3.11. Bioresearch Technologies
    • 12.3.12. Promega Corporation
    • 12.3.13. Illumina, Inc.
    • 12.3.14. Aurora Biomed Inc.
    • 12.3.15. Hygiena LLC
    • 12.3.16. Tecan Trading AG
    • 12.3.17. MACHEREY-NAGEL GmbH & Co. KG
    • 12.3.18. Ahlstrom
    • 12.3.19. Nanodigmbio (Nanjing) Biotechnology Co., Ltd.
    • 12.3.20. Bionano Genomics, Inc.
    • 12.3.21. Revvity
    • 12.3.22. F. Hoffmann-La Roche Ltd
    • 12.3.23. New England Biolabs

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations